Fermitin family member 2 (FERMT2)

Fermitin family member 2 (FERMT2), widely known as Kindlin-2, is a critical scaffolding protein that resides at focal adhesions and is essential for the regulation of integrin-mediated cell signaling. It functions primarily as an activator of integrins by binding to their cytoplasmic tails, a process that is vital for cell adhesion, spreading, and migration across various tissue types. Beyond its structural role, FERMT2 serves as a signaling hub that modulates key pathways such as Wnt/beta-catenin and TGF-beta, thereby influencing cell differentiation, gene expression, and tissue development. In clinical contexts, FERMT2 is recognized as a potent driver of cancer progression, where its overexpression is linked to epithelial-to-mesenchymal transition (EMT), increased metastatic potential, and poor patient prognosis in malignancies like breast, gastric, and colorectal cancers. Additionally, it has emerged as a significant genetic risk factor for Alzheimer's disease due to its role in regulating amyloid precursor protein (APP) metabolism and synaptic plasticity. While FERMT2 represents a high-value therapeutic target for inhibiting metastasis and neurodegeneration, its fundamental necessity for embryonic survival and cardiac function poses substantial challenges for the development of safe, systemically administered inhibitors.

Other names

Kindlin-2KIND2MIG2PLEKHC1UNC112BFermitin family homolog 2Mitogen-inducible gene 2 proteinPH domain-containing family C member 1

FERMT2 acts as an essential co-activator of integrins by binding directly to the distal NPxY motif of the beta-integrin cytoplasmic tail, which facilitates the conformational change to a high-affinity state (inside-out signaling) and stabilizes focal adhesions by linking integrins to the actin cytoskeleton.